1. AHRO : Austin Health Research Online

Peter P De Cruz

View Statistics Email Alert

Profile

Loading... 2 0 5 0 false
Credit Name
Peter P De Cruz
Full Name
De Cruz, Peter P
 
Variants
De Cruz, Peter
 
Department
 
ORCID
Loading... 3 0 5 0 false

Publications

Results 1-20 of 24 (Search time: 0.014 seconds).

Publication YearTitleAuthor(s)
11-Nov-2020Luminal microbiota related to Crohn's disease recurrence after surgery.Hamilton, Amy L; Kamm, Michael A; De Cruz, Peter P ; Wright, Emily K; Feng, Hai; Wagner, Josef; Sung, Joseph J Y; Kirkwood, Carl D; Inouye, Michael; Teo, Shu-Mei
2Sep-2020Immune therapies in ulcerative colitis: are we beyond anti-TNF yet?Raine, Tim; Verstockt, Bram; De Cruz, Peter P 
316-Aug-2020Tofacitinib is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis.Gilmore, Robert ; Hilley, Patrick; Srinivasan, Ashish ; Choy, Matthew C ; Grace, Josephine A ; De Cruz, Peter P 
414-Aug-2020Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford.Pulusu, Samba Siva Reddy; Srinivasan, Ashish ; Krishnaprasad, Krupa; Cheng, Daniel; Begun, Jakob; Keung, Charlotte; Van Langenberg, Daniel; Thin, Lena; Mogilevski, Tamara; De Cruz, Peter P ; Radford-Smith, Graham; Flanagan, Emma; Bell, Sally; Kashkooli, Soleiman; Sparrow, Miles; Ghaly, Simon; Bampton, Peter; Sawyer, Elise; Connor, Susan; Rizvi, Quart-Ul-Ain; Andrews, Jane M; Mahy, Gillian; Chivers, Paola; Travis, Simon; Lawrance, Ian Craig
5Aug-2020Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail.Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
6Aug-2020Letter: ustekinumab dose intensification for loss of response-should we re-induce before shortening the dose interval?Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
717-Jul-2020Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach.Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
8Jun-2020Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis?Li Wai Suen, Christopher F D; Choy, Matthew C ; De Cruz, Peter P 
9Jun-2020A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's disease.Srinivasan, Ashish ; van Langenberg, Daniel R; Little, Robert D; Sparrow, Miles P; De Cruz, Peter P ; Ward, Mark G
1011-Apr-2020Letter to the Editor: Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial.Gilmore, Robert ; Choy, Matthew C ; Li Wai Suen, Christopher F D; De Cruz, Peter P 
1111-Apr-2020Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel DiseasePeverelle, Matthew R ; Mills, Chris; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P 
1231-Mar-2020Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient.Peverelle, Matthew R ; Asadi, Khashayar; De Cruz, Peter P 
13Mar-2020Letter: infliximab induction regimens in steroid-refractory acute severe colitis-a propensity score analysis.Li Wai Suen, Christopher F D; Choy, Matthew C ; De Cruz, Peter P 
1420-Feb-2020Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.Peverelle, Matthew R ; Mills, Christopher D; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P 
1516-Jan-2020Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.Peverelle, Matthew R ; Paleri, Sarang; Hughes, Jed ; De Cruz, Peter P ; Gow, Paul J 
162020Using Ustekinumab to Treat Crohn's Disease-Related Orofacial Granulomatosis: Two Birds, One Stone.Gilmore, Robert ; Li Wai Suen, Christopher F D; Elliott, Tim; De Cruz, Peter P ; Srinivasan, Ashish 
1723-Aug-2019A Framework to support Quality of Care for patients with Chronic Intestinal Failure requiring Home Parenteral Nutrition.Osland, Emma J; McGrath, Kathleen H; Ali, Azmat; Carey, Sharon; Daniells, Suzie; Angstmann, Katerina; Bines, Julie; Asrani, Varsha; Watson, Caitlin; Jones, Lynn; De Cruz, Peter P 
18Aug-2019Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies.Sasadeusz, Joe; Grigg, Andrew P ; Hughes, Peter D; Lim, Seng Lee; Lucas, Michaela; McColl, Geoff; McLachlan, Sue Anne; Peters, Marion G; Shackel, Nicholas; Slavin, Monica; Sundararajan, Vijaya; Thompson, Alexander; Doyle, Joseph; Rickard, James; De Cruz, Peter P ; Gish, Robert G; Visvanathan, Kumar
192019Quality of Care in Patients With Inflammatory Bowel Disease.Jackson, Belinda D ; De Cruz, Peter P 
202019Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.Choy, Matthew C ; Seah, Dean ; Faleck, David M; Shah, Shailja C; Chao, Che-Yung; An, Yoon-Kyo; Radford-Smith, Graham; Bessissow, Talat; Dubinsky, Marla C; Ford, Alexander C; Churilov, Leonid ; Yeomans, Neville D ; De Cruz, Peter P